Revised National Tuberculosis Control Programme
The Revised National Tuberculosis Control Programme is a publicly mandated tuberculosis control initiative with approximately 80 employees based in Lakshadweep, India, operating as a territorial implementation unit under India's national TB control framework. No commercial operating data is disclosed in the input.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Revised National Tuberculosis Control Programme does
The Revised National Tuberculosis Control Programme (RNTCP) is, on the basis of its name, an Indian public-sector tuberculosis control initiative operating as part of the national disease-control framework. The supplied firmographic data describes an entity with approximately 80 employees and a presence in Lakshadweep, a Union Territory of India, suggesting this is a territorial or state-level implementation unit rather than the national coordinating body. The associated web reference (tbfacts.org/rntcp/) points to a third-party informational site documenting RNTCP activities rather than to an official operating site, and the source content explicitly notes that no substantive material about RNTCP was returned in the aggregated sources — the source blocks pertain to unrelated entities (Education New Zealand and POS4D). Consequently, no product, technology stack, service delivery mechanism, or commercial operating model can be evidenced from the input; the entity is treated as a public health delivery unit without disclosed revenue mechanics. Business model, pricing, and go-to-market are not applicable in a commercial sense, as operations are presumed to be funded by government budgetary allocation rather than user fees or commercial contracts.
Revised National Tuberculosis Control Programme firmographics
Firmographics- Name
- Revised National Tuberculosis Control Programme
- Website
- https://tbfacts.org
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Revised National Tuberculosis Control Programme is a publicly mandated tuberculosis control initiative with approximately 80 employees based in Lakshadweep, India, operating as a territorial implementation unit under India's national TB control framework. No commercial operating data is disclosed in the input.
- Ownership category
- akta.pro rank
Revised National Tuberculosis Control Programme industry classification
Industry- Product category
- Public Health Services
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Tuberculosis & Mycobacterial Diseases (HLAKAGAH)
- akta.pro secondary industry
- Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)
Keywords
Revised National Tuberculosis Control Programme business model
Business model- GTM type
- B2C
- Offering type
- Services
Revised National Tuberculosis Control Programme product offering
Product offeringCore offering
The Revised National Tuberculosis Control Programme (RNTCP) is referenced via its informational page at tbfacts.org. Based on its name, it is a national public health programme addressing tuberculosis prevention, diagnosis, and treatment in India. The provided input does not contain detailed substantive content describing its operational offerings.
Differentiator
Problem solved
Functional benefit
Revised National Tuberculosis Control Programme technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Revised National Tuberculosis Control Programme competitors and assessment
Company assessmentEmerging players
- FIND (Foundation for Innovative New Diagnostics): Works with India's TB programme on diagnostic scale-up (e.g., molecular testing, CBNAAT). Comparable because it operates at the intersection of national TB policy and on-the-ground diagnostic deployment.
- TB Alliance: Product development partnership advancing new TB drug regimens. Comparable in being an India-active TB-focused organisation, but operating upstream in R&D rather than district-level program implementation.
Broad incumbents
- National Health Mission (NHM): The umbrella mission under which RNTCP and other disease-control verticals operate. Comparable because it channels funding, sets norms, and supervises district-level implementation units that mirror the entity's likely operating model.
- WHO Global TB Programme: Sets global TB policy, norms, and technical guidance that shape RNTCP implementation in India. Relevant peer for benchmarking program design, surveillance standards, and donor alignment rather than as a direct competitor.
Others
- The Global Fund to Fight AIDS, Tuberculosis and Malaria: Major external financier of India's TB programme. Comparable as a funder whose grant cycles and reporting requirements shape how an RNTCP-aligned implementer must operate and report.
- Stop TB Partnership: Multilateral platform coordinating donors, governments, and implementers in TB-endemic countries. Comparable as an ecosystem orchestrator that the entity may partner with or receive funding from, rather than compete with.
Direct peers
- Central TB Division, Directorate of Health Services (India): The federal body that runs the actual RNTCP and Ni-kshay platform. It is the most direct peer because any entity claiming RNTCP affiliation is essentially contracting with or operating under this division's policy and budget authority.
- National AIDS Control Organisation (NACO): India's parallel vertical disease-control programme under the National Health Mission. Highly comparable as a sister public-health programme with similar governance, district-level implementation model, donor co-financing structure, and reporting cadence.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat1 record
Key risks4 records
Key highlights2 records
Customer concentration
Revised National Tuberculosis Control Programme social profiles
Digital presenceRevised National Tuberculosis Control Programme financial estimates
Financial estimateRevenue estimate
Valuation estimate
Revised National Tuberculosis Control Programme leadership team
Management profileNumber of profiles
Revised National Tuberculosis Control Programme funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Revised National Tuberculosis Control Programme M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Revised National Tuberculosis Control Programme
What does Revised National Tuberculosis Control Programme do?
The Revised National Tuberculosis Control Programme (RNTCP) is referenced via its informational page at tbfacts.org. Based on its name, it is a national public health programme addressing tuberculosis prevention, diagnosis, and treatment in India. The provided input does not contain detailed substantive content describing its operational offerings.
When was Revised National Tuberculosis Control Programme founded?
Revised National Tuberculosis Control Programme was founded in -1. It employs 51 to 100 people.
Who are Revised National Tuberculosis Control Programme's main competitors?
Emerging players on record are FIND (Foundation for Innovative New Diagnostics) and TB Alliance. Broad incumbents are National Health Mission (NHM) and WHO Global TB Programme. Others are The Global Fund to Fight AIDS, Tuberculosis and Malaria and Stop TB Partnership. Direct peers are Central TB Division, Directorate of Health Services (India) and National AIDS Control Organisation (NACO).
Does Revised National Tuberculosis Control Programme have an API?
No public API is recorded for Revised National Tuberculosis Control Programme.
What industry is Revised National Tuberculosis Control Programme in?
Revised National Tuberculosis Control Programme's product category is Public Health Services. Its primary akta.pro industry code is HLAKAGAH, Tuberculosis & Mycobacterial Diseases, with a secondary code of HLAJAOAE, Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs). Its SIC code is 8000.